Gynotech

Company Overview

Snapshot

Founded in June 2016 by Abraham Nissenkorn, Gynotech operates with 1–10 employees. The company holds a patent for its technology. In July 2022, Gynotech ceased operations.

Business overview

Gynotech develops medical devices for women's health, specifically focusing on treating and preventing female urinary incontinence and uterine prolapse. Its core product, GynoPess, is a smart vaginal ring pessary that features dynamic electromechanical capabilities and built-in sensors. This device detects physiological changes and adjusts its diameter to provide more effective support, while also recording intra-abdominal pressure data to facilitate personalized uro-gynecological treatment. Gynotech operates within the Health Tech & Life Sciences sector, serving markets such as the United States and Japan.

Company Intelligence Q&A

What is Gynotech's primary product?

Gynotech's primary product is GynoPess, a smart vaginal ring pessary designed to treat and prevent female urinary incontinence and uterine prolapse.

When was Gynotech founded?

Gynotech was founded in June 2016.

What is the core technology behind GynoPess?

GynoPess is a dynamic electromechanical ring with built-in sensors that detect changing physiological parameters and make instant adjustments to the ring's diameter.

What markets does Gynotech target?

Gynotech targets geomarkets including the United States and Japan.

What is the current operational status of Gynotech?

Gynotech ceased to operate in July 2022.